Sherbrooke Park Advisers’s Merck MRK Stock Holding History

Sherbrooke Park Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,029	Closed	-$1.44M	–	680
2025 Q1	$1.44M	Buy	16,029 +7,971	+99%	+$744K	0.67%	3
2024 Q4	$802K	Sell	8,058 -4,894	-38%	-$505K	0.26%	95
2024 Q3	$1.47M	Buy	12,952 +3,329	+35%	+$396K	0.34%	30
2024 Q2	$1.19M	Buy	+9,623	New	+$1.24M	0.21%	139
2024 Q1	–	Sell	-5,819	Closed	-$634K	–	946
2023 Q4	$634K	Sell	5,819 -3,374	-37%	-$350K	0.3%	118
2023 Q3	$946K	Buy	+9,193	New	+$991K	0.3%	115

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sherbrooke Park Advisers's MRK Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Merck (MRK) in Q2 2025, closing a stake of 16,029 shares — an estimated $1.44M sold.

Sherbrooke Park Advisers first reported a position in MRK in Q3 2023 and held it in 6 quarters. The position peaked at $1.47M in Q3 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

Sherbrooke Park Advisers reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 16,029 Merck shares in Q2 2025, an estimated $1.44M.
Sherbrooke Park Advisers first reported a position in Merck in Q3 2023 and held it in 6 quarters.
Sherbrooke Park Advisers's Merck position peaked at $1.47M in Q3 2024.
3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.